CoChat
Sign Up
Cited by 3,187Chronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesInhalation and Respiratory Drug Delivery

The DOI matches its Crossref record; 304 of the 305 references it cites were found in a registry or an index.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

Open access
Vogelmeier, Claus F., Criner, Gerard J., Martinez, Fernando J., Anzueto, Antonio, Barnes, Peter J., Bourbeau, Jean, Celli, Bartolome R., Chen, Rongchang, Decramer, Marc, Fabbri, Leonardo M., Frith, Peter, Halpin, David M. G., López Varela, M. Victorina, Nishimura, Masaharu, Roche, Nicolas, Rodriguez-Roisin, Roberto, Sin, Don D., Singh, Dave, Stockley, Robert, Vestbo, Jørgen, Wedzicha, Jadwiga A., Agustí, Alvar·2017·American Journal of Respiratory and Critical Care Medicine
DOI 10.1164/rccm.201701-0218pp
Open this paper in CoChat — free accountOpen PDF

Abstract

This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201701-0218pp

Cites

304 of 304 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

1 of the 305 references couldn’t be matched to a known paper.

Research works printed but not linked: 34

  1. Medical Research Council Committee on the Aetiology of Chronic Bronchitis, 1965, Definition and classification of chronic bronchitis for clinical and epidemiological purposes: a report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis, Lancet, 1, 775
  2. Fletcher, 1960, Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score), BMJ, 2, 1662
  3. National Institute for Health and Care Excellence, 2016, Multimorbidity: clinical assessment and management, in press
  4. 1997, Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ, 75, 397
  5. van Eerd, 2016, Smoking cessation for people with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD010744
  6. van der Meer, 2003, Smoking cessation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002999
  7. McNeill, 2015, E-cigarettes: an evidence update
  8. McRobbie, 2014, Electronic cigarettes for smoking cessation and reduction, Cochrane Database Syst Rev, 12, CD010216
  9. Cahill, 2013, Pharmacological interventions for smoking cessation: an overview and network meta-analysis, Cochrane Database Syst Rev, 5, CD009329
  10. Stead, 2013, Physician advice for smoking cessation, Cochrane Database Syst Rev, 5, CD000165
  11. Stead, 2016, Combined pharmacotherapy and behavioural interventions for smoking cessation, Cochrane Database Syst Rev, 3, CD008286
  12. Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002733
  13. Wongsurakiat, 2003, Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients, J Med Assoc Thai, 86, 497
  14. Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1
  15. Appleton, 2006, Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD006101
  16. Karner, 2014, Tiotropium versus placebo for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD009285
  17. Ram, 2002, Oral theophylline for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD003902
  18. Nannini, 2012, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 9, CD006829
  19. Nannini, 2013, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 8, CD006826
  20. Yang, 2012, Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD002991
  21. Chong, 2013, Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 11, CD002309
  22. Poole, 2015, Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001287
  23. Puhan, 2011, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD005305
  24. Kruis, 2013, Integrated disease management interventions for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 10, CD009437
  25. Halpin, 2009, Palliative and end-of-life care for patients with respiratory diseases, Eur Respir Monograph, 43, 327
  26. Cranston, 2005, Domiciliary oxygen for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001744
  27. Barr, 2005, Inhaled tiotropium for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002876
  28. Karner, 2012, Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 4, CD008989
  29. Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 63, 822
  30. Tiong, 2006, Lung volume reduction surgery for diffuse emphysema, Cochrane Database Syst Rev, CD001001
  31. Vollenweider, 2012, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 12, CD010257
  32. Ram, 2006, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD004403
  33. Schuetz, 2012, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, Cochrane Database Syst Rev, CD007498
  34. Bradley, 1985, Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome, Am Rev Respir Dis, 131, 835

Cited by

Sorted by citations

See all 3,187

Related

See all

Metadata

Authors
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Agustí, A.
Affiliations
  • Philipps University of Marburg (DE)
  • Temple University (US)
  • New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
  • The University of Texas at San Antonio Health Science Center (US)
  • Imperial College London (GB)
  • McGill University Health Centre (CA)
  • Brigham and Women’s Hospital, Boston, Massachusetts
  • First Affiliated Hospital of Guangzhou Medical University (CN)
  • KU Leuven (BE)
  • University of Modena and Reggio Emilia (IT)
  • Flinders University (AU)
  • Royal Devon and Exeter Hospital (GB)
  • Universidad de la República, Hospital Maciel, Montevideo, Uruguay
  • Hokkaido University (JP)
  • Hôpital Cochin (Assistance Publique–Hôpitaux de Paris), University Paris Descartes, Paris, France
  • Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain
  • University of British Columbia (CA)
  • University Hospital, Birmingham, United Kingdom; and
  • University of Manchester (GB)
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
Corresponding author
Vogelmeier, Claus F.
ORCID
Venue
American Journal of Respiratory and Critical Care Medicine
Publisher
Oxford University Press (OUP)
Published
2017-03-01
Volume
195
Issue
5
Pages
557-582
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
DOI
10.1164/rccm.201701-0218pp
OpenAlex
W2583265473
Cited by
3,187
References
305
Citations by year
2026: 118 · 2025: 162 · 2024: 247 · 2023: 307 · 2022: 415 · 2021: 441 · 2020: 449 · 2019: 436 · 2018: 428 · 2017: 173
FWCI
336.54
Type
journal article
Language
en
Open access
Licence
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
National Institute for Health and Care Research (NF-SI-0510-10270, NF-SI-0513-10077, NF-SI-0611-10148)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords
chronic obstructive pulmonary disease, GOLD 2017, COPD diagnosis, COPD management, COPD prevention, exacerbations, non-pharmacological treatment, comorbidities, spirometry, symptom assessment
MeSH terms
Bronchodilator Agents, Humans, Risk Factors, Spirometry, Global Health, Pulmonary Disease, Chronic Obstructive, Internationality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review